COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,284 Articles (22,759 medRxiv, 8,525 bioRxiv)

Most recent first Previous |  Page 2168: Articles 21671-21680  | Next

Nonspecific blood tests as proxies for COVID-19 hospitalization: are there plausible associations after excluding noisy predictors?
Ishikawa, G., Argenti, G., Fadel, C. B.
10.1101/2020.10.12.20211557 — Posted: 2020-10-14
Precautionary breaks: planned, limited duration circuit breaks to control the prevalence of COVID-19
Keeling, M. J., Guyver-Fletcher, G., Holmes, A., Dyson, L. J., Tildesley, M., Hill, E. M., Medley, G. F.
10.1101/2020.10.13.20211813 — Posted: 2020-10-14
Symptom-based testing in a compartmental model of COVID-19
Bartha, F. A., Karsai, J., Tekeli, T., Röst, G.
10.1101/2020.10.11.20211037 — Posted: 2020-10-14
What is the evidence for transmission of COVID-19 by children in schools? A living systematic review
Xu, W., Li, X., Dozier, M., He, Y., Kirolos, A., Lang, Z., Mathews, C., Siegfried, N., Theodoratou, E.
10.1101/2020.10.11.20210658 — Posted: 2020-10-14
A delayed modulation of solar radiation on the COVID-19 transmission reflects an incubation period
He, M., Fang, K., Feifei, Z., Ou, T., Chen, D.
10.1101/2020.10.13.20183111 — Posted: 2020-10-14
School closures and SARS-CoV-2. Evidence from Sweden's partial school closure
Vlachos, J., Hertegard, E., Svaleryd, H. B.
10.1101/2020.10.13.20211359 — Posted: 2020-10-14
A comparative study of infection and mortality in COVID-19 across countries: A scaling analysis
Das, R., Hossain, A., Mandal, S., Pariari, D., Rohj, R. K., Shukla, S., Varma, R. M., Das Sarma, D.
10.1101/2020.10.13.20212175 — Posted: 2020-10-14
Mathematical Perspective of Covid-19 Pandemic: Disease Extinction Criteria in Deterministic and Stochastic Models
Adak, D., Majumder, A., Bairagi, N.
10.1101/2020.10.12.20211201 — Posted: 2020-10-14
Epidemiologial Analysis of Patients Presenting to a West London District General Hospital Requiring Admission with Covid-19
Heald, E., Ring, N., Vatvani, D., Shackleton, D.
10.1101/2020.10.13.20212126 — Posted: 2020-10-14
Healthcare workers with mild / asymptomatic SARS-CoV-2 infection show T cell responses and neutralising antibodies after the first wave
Reynolds, C. J., Swadling, L., Gibbons, J. M., Pade, C., Jensen, M., Diniz, M. O., Schmidt, N. M., Butler, D. K., Amin, O. E., Bailey, S. N. L., Talyor, S., Jones, J., Jones, M., Lee, W. Y. J., Rosenheim, J., Chandran, A., Joy, G., Di Genova, C., Temperton, N. J., Lambourne, J., Cutino-Moguel, T., Andiapen, M., Fontana, M., Smit, A., Semper, A., O'Brien, B., Chain, B., Brooks, T., Manisty, C., Treibel, T., Moon, J., COVIDsortium Investigators, , Noursadeghi, M. C., COVIDsortium Immune correlates network, , Altmann, D. M., Mani, M. K., McKnight, A., Boyton, R. J.
10.1101/2020.10.13.20211763 — Posted: 2020-10-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).